Description

6-(3,5-Dimethylmorpholino)Pyridazin-3-Amine is a high-purity, advanced pharmaceutical intermediate characterized by its unique heterocyclic structure combining pyridazine and morpholine motifs. This compound is of significant value in medicinal chemistry for its role as a versatile building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and pharmaceutical companies engaged in the development of new therapeutic agents, particularly within central nervous system (CNS) and oncology research pipelines.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• CNS Drug Development: Employed in the research and synthesis of potential therapeutics for neurological and psychiatric disorders.
• Oncology Research: Serves as a building block for creating molecules evaluated for anti-cancer properties.
• Chemical Biology Probes: Utilized in the development of tool compounds for studying biological processes and target validation.
• Contract Manufacturing (CMO): Supplied to contract manufacturing organizations for scale-up synthesis under cGMP conditions.
• Academic Research: Used in university and institutional labs for fundamental research in organic synthesis and heterocyclic chemistry.

Basic Information

Product Name	6-(3,5-Dimethylmorpholino)Pyridazin-3-Amine
CAS No.	736879-79-1
Molecular Formula	C10H16N4O
Molecular Weight	208.26 g/mol
Synonyms	6-(3,5-Dimethyl-4-morpholinyl)-3-pyridazinamine; 3-Amino-6-(3,5-dimethylmorpholino)pyridazine; 6-(3,5-Dimethylmorpholin-4-yl)pyridazin-3-amine; 736879-79-1; 6-(3,5-Dimethyl-4-morpholinyl)pyridazin-3-amine; 3-Pyridazinamine, 6-(3,5-dimethyl-4-morpholinyl)-; 6-(3,5-Dimethylmorpholin-4-yl)-3-pyridazinamine
EINECS	Contact for details

Quality Control

Our 6-(3,5-Dimethylmorpholino)Pyridazin-3-Amine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical research and development. Certificates of Analysis (COA) with complete batch data are provided and can be tailored to meet specific client or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed under an inert atmosphere (e.g., nitrogen or argon) to prevent oxidation and moisture absorption. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.